ビソプロロールの世界市場レポート 2025年

ビソプロロール市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で30億3,000万米ドルに成長します。予測期間の成長は、心血管専門クリニックの増加、患者支援プログラムの充実、生活習慣病罹患率の上昇、臨床試験や調査研究の増加、心血管健康イニシアチブへの資金提供の増加などに起因しています。予測期間における主な動向には、ドラッグデリバリーシステムの進歩、患者中心の治療法の開発、薬剤開発における人工知能の統合、心血管診断の進歩などがあります。

高血圧の有病率の上昇は、今後のビソプロロール市場の成長を促進すると予測されます。高血圧症は、座りがちなライフスタイル、肥満、不健康な食生活などの要因に影響され、常に血圧値が上昇することが特徴です。ビソプロロールは、心臓の仕事量を減らし、血流を改善することによって血圧を下げるために利用されます。例えば、2024年5月、シンガポール心臓財団は、高血圧性疾患による死亡者数が2021年の3.4％から2022年には3.7％になったと報告しました。このように、高血圧の有病率の増加はビソプロロール市場を押し上げると予想されます。

ビソプロロール市場の主なプレーヤーは、アクセシビリティを高め、コストを削減し、市場でのプレゼンスを拡大するために、ジェネリック医薬品の組み合わせなどの革新的な製剤の開発に注力しています。これらのジェネリック医薬品は、心拍数を低下させ循環を改善することで、高血圧、心不全、狭心症の管理に役立ちます。例えば、ザイダス・ライフサイエンシズ・リミテッドは2022年11月、フマル酸塩とヒドロクロロチアジドの徐放錠のジェネリック医薬品として米国食品医薬品局（FDA）から最終承認を取得しました。この製剤は、心拍数と血圧を低下させるβ遮断薬であるビソプロロールと、体液貯留を減少させる利尿薬であるヒドロクロロチアジドを組み合わせたものです。この製剤は、心拍数と血圧を低下させるβ遮断薬であるビソプロロールと、体液貯留を抑える利尿薬であるヒドロクロロチアジドを組み合わせたもので、1錠の徐放性錠剤で効果的な血圧管理を実現し、患者の服薬アドヒアランスの向上と高血圧の長期管理を促進します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ビソプロロールPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のビソプロロール市場：成長率分析
• 世界のビソプロロール市場の実績：規模と成長, 2019-2024
• 世界のビソプロロール市場の予測：規模と成長, 2024-2029, 2034F
• 世界ビソプロロール総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のビソプロロール市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤
• カプセル
• 世界のビソプロロール市場流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界のビソプロロール市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高血圧
• 冠動脈疾患
• 狭心症
• その他の用途

第7章 地域別・国別分析

• 世界のビソプロロール市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のビソプロロール市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ビソプロロール市場：競合情勢
• ビソプロロール市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Healthcare Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intas Pharmaceuticals Limited
• Cipla Limited
• Hikma Pharmaceuticals
• Lupin Limited
• Dr. Reddy's Laboratories Limited
• Glenmark Pharmaceuticals Limited
• Alkem Laboratories Limited
• Ipca Laboratories Limited
• Medreich Limited
• Alembic Pharmaceuticals Limited
• Accord Healthcare Limited
• Zydus Lifesciences Limited
• Zentiva Group
• Taj Pharmaceuticals Limited
• Torrent Pharmaceuticals Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ビソプロロール市場2029：新たな機会を提供する国
• ビソプロロール市場2029：新たな機会を提供するセグメント
• ビソプロロール市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bisoprolol is a beta-blocker used to treat high blood pressure, heart failure, and angina (chest pain). It functions by inhibiting the effects of adrenaline on the heart, which decreases heart rate and blood pressure, thereby easing the heart's workload.

Bisoprolol primarily comes in tablet and capsule forms. The tablet version is a solid oral medication intended for managing cardiovascular issues, providing a convenient and easily administered option for patients. It is generally prescribed in specific doses that facilitate a controlled release of the medication over time. Distribution channels include hospital pharmacies, retail pharmacies, and others, targeting conditions such as high blood pressure, coronary heart disease, and angina pectoris, among others.

The bisoprolol market research report is one of a series of new reports from the business research company that provides bisoprolol market statistics, including bisoprolol industry global market size, regional shares, competitors with an bisoprolol market share, detailed bisoprolol market segments, market trends and opportunities, and any further data you may need to thrive in the bisoprolol industry. This bisoprolol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisoprolol market size has grown strongly in recent years. It will grow from $2 billion in 2024 to $2.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing aging population, expanding availability of generic drugs, increasing awareness of hypertension management, increased healthcare expenditure.

The bisoprolol market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the growth of cardiovascular specialty clinics, enhanced availability of patient support programs, a rise in lifestyle-related disease incidences, a rising number of clinical trials and research studies, and increased funding for cardiovascular health initiatives. Major trends in the forecast period include advancements in drug delivery systems, development of patient-centric therapies, integration of artificial intelligence in drug development, and advancements in cardiovascular diagnostics.

The rising prevalence of hypertension is anticipated to drive the growth of the bisoprolol market in the future. Hypertension is characterized by consistently elevated blood pressure levels, influenced by factors such as sedentary lifestyles, obesity, and unhealthy diets. Bisoprolol is utilized to lower blood pressure by reducing the heart's workload and improving blood flow. For instance, in May 2024, the Singapore Heart Foundation reported that deaths due to hypertensive diseases accounted for 3.7% in 2022, up from 3.4% in 2021. Thus, the increasing prevalence of hypertension is expected to boost the bisoprolol market.

Key players in the bisoprolol market are focused on developing innovative formulations, such as generic combinations, to enhance accessibility, reduce costs, and expand their market presence. These generic combinations help manage high blood pressure, heart failure, and angina by lowering heart rate and improving circulation. For example, in November 2022, Zydus Lifesciences Limited received final approval from the U.S. Food and Drug Administration (FDA) for its extended-release bisoprolol fumarate and hydrochlorothiazide tablets in generic form. This formulation combines the beta-blocker bisoprolol, which decreases heart rate and blood pressure, with hydrochlorothiazide, a diuretic that reduces fluid retention. Together, they provide effective blood pressure management in a single extended-release tablet, promoting better patient adherence and long-term control of hypertension.

In April 2023, SK Capital Partners, LP, a U.S.-based private investment firm, acquired Apotex Inc. for an undisclosed amount. This acquisition aims to bolster Apotex's capabilities, accelerate growth, and foster innovation in the production of high-quality, affordable medicines globally. Apotex Inc. is a Canadian pharmaceutical company and a manufacturer of bisoprolol.

Major companies operating in the bisoprolol market are Merck & Co. Inc., Abbott Healthcare Pvt Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Dr. Reddy's Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Ipca Laboratories Limited, Medreich Limited, Alembic Pharmaceuticals Limited, Accord Healthcare Limited, Zydus Lifesciences Limited, Zentiva Group, Taj Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Suanfarma, Rusan Healthcare Limited, VHB Lifesciences Limited, Synnat Pharmaceuticals, Vidakem Lifesciences Pvt Ltd, Pluviaendo Pharmaceuticals

North America was the largest region in the bisoprolol market in 2023. The regions covered in the bisoprolol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bisoprolol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisoprolol market consists of sales of generic medicine, extended-release tablets, and oral solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisoprolol Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bisoprolol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisoprolol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bisoprolol market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Tablet; Capsule
• 2) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 3) By Application: High Blood Pressure; Coronary Heart Disease; Angina Pectoris; Other Applications
• Subsegments:
• 1) By Tablet: Standard Bisoprolol Tablets; Extended-Release Bisoprolol Tablets
• 2) By Capsule: Standard Bisoprolol Capsules; Extended-Release Bisoprolol Capsules
• Companies Mentioned: Merck & Co. Inc.; Abbott Healthcare Pvt Ltd; Novartis AG; Teva Pharmaceutical Industries Ltd; Aurobindo Pharma Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bisoprolol Market Characteristics

3. Bisoprolol Market Trends And Strategies

4. Bisoprolol Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bisoprolol Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bisoprolol PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bisoprolol Market Growth Rate Analysis
• 5.4. Global Bisoprolol Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bisoprolol Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bisoprolol Total Addressable Market (TAM)

6. Bisoprolol Market Segmentation

• 6.1. Global Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Capsule
• 6.2. Global Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels
• 6.3. Global Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Blood Pressure
• Coronary Heart Disease
• Angina Pectoris
• Other Applications

7. Bisoprolol Market Regional And Country Analysis

• 7.1. Global Bisoprolol Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bisoprolol Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bisoprolol Market

• 8.1. Asia-Pacific Bisoprolol Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bisoprolol Market

• 9.1. China Bisoprolol Market Overview
• 9.2. China Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bisoprolol Market

• 10.1. India Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bisoprolol Market

• 11.1. Japan Bisoprolol Market Overview
• 11.2. Japan Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bisoprolol Market

• 12.1. Australia Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bisoprolol Market

• 13.1. Indonesia Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bisoprolol Market

• 14.1. South Korea Bisoprolol Market Overview
• 14.2. South Korea Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bisoprolol Market

• 15.1. Western Europe Bisoprolol Market Overview
• 15.2. Western Europe Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bisoprolol Market

• 16.1. UK Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bisoprolol Market

• 17.1. Germany Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bisoprolol Market

• 18.1. France Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bisoprolol Market

• 19.1. Italy Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bisoprolol Market

• 20.1. Spain Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bisoprolol Market

• 21.1. Eastern Europe Bisoprolol Market Overview
• 21.2. Eastern Europe Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bisoprolol Market

• 22.1. Russia Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bisoprolol Market

• 23.1. North America Bisoprolol Market Overview
• 23.2. North America Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bisoprolol Market

• 24.1. USA Bisoprolol Market Overview
• 24.2. USA Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bisoprolol Market

• 25.1. Canada Bisoprolol Market Overview
• 25.2. Canada Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bisoprolol Market

• 26.1. South America Bisoprolol Market Overview
• 26.2. South America Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bisoprolol Market

• 27.1. Brazil Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bisoprolol Market

• 28.1. Middle East Bisoprolol Market Overview
• 28.2. Middle East Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bisoprolol Market

• 29.1. Africa Bisoprolol Market Overview
• 29.2. Africa Bisoprolol Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bisoprolol Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bisoprolol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bisoprolol Market Competitive Landscape And Company Profiles

• 30.1. Bisoprolol Market Competitive Landscape
• 30.2. Bisoprolol Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Healthcare Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

31. Bisoprolol Market Other Major And Innovative Companies

• 31.1. Intas Pharmaceuticals Limited
• 31.2. Cipla Limited
• 31.3. Hikma Pharmaceuticals
• 31.4. Lupin Limited
• 31.5. Dr. Reddy's Laboratories Limited
• 31.6. Glenmark Pharmaceuticals Limited
• 31.7. Alkem Laboratories Limited
• 31.8. Ipca Laboratories Limited
• 31.9. Medreich Limited
• 31.10. Alembic Pharmaceuticals Limited
• 31.11. Accord Healthcare Limited
• 31.12. Zydus Lifesciences Limited
• 31.13. Zentiva Group
• 31.14. Taj Pharmaceuticals Limited
• 31.15. Torrent Pharmaceuticals Limited

32. Global Bisoprolol Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bisoprolol Market

34. Recent Developments In The Bisoprolol Market

35. Bisoprolol Market High Potential Countries, Segments and Strategies

• 35.1 Bisoprolol Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bisoprolol Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bisoprolol Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer